Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_assertion type Assertion NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_head.
- NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_assertion description "[By using the band intensity ratios of SCCA2 to beta-actin, with a positive cut-off value of > or = 0.4, the positive rates of the SCCA2 mRNA expression in peripheral blood were found to be 82% (41/50), 60% (30/50), 48% (24/50), and 36% (18/50) in the cancer, dysplasia, basal cell hyperplasia, and control groups, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_provenance.
- NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_assertion evidence source_evidence_literature NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_provenance.
- NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_assertion SIO_000772 19125792 NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_provenance.
- NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_assertion wasDerivedFrom befree-20140225 NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_provenance.
- NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_assertion wasGeneratedBy ECO_0000203 NP444116.RA5H3iGKXVMcg8BYCSG6bYWiaQA8b0K3z_XWXAsgSNT7w130_provenance.